Assessment of gut microbial & beta;-glucuronidase and & beta;-glucosidase activity in women with polycystic ovary syndrome

PCOS is a prevalent endocrine disorder among women of reproductive age, characterized by hormonal imbalances and metabolic disturbances. This study explores the correlation between gut microbial & beta;-glucuronidase and & beta;-glucosidase and PCOS, focusing on their association with hormone levels and other clinical parameters. In this case-control study, fecal samples were collected from women of reproductive age, both with and without PCOS. The analysis of gut & beta;-glucuronidase and & beta;-glucosidase enzymes was conducted with the other clinical parameters, including body mass index, hormone levels, and hirsutism. These factors were then subjected to correlation analysis. PCOS women showed significantly higher levels of & beta;-glucuronidase activity with a statistically significant P-value (0.05 & PLUSMN; 0.1 vs. 0.04 & PLUSMN; 0.1; P = 0.006) as well as & beta;-glucosidase activity (0.13 & PLUSMN; 0.08 vs. 0.09 & PLUSMN; 0.05; P = 0.06) compared to the controls. This study also revealed intriguing connections between the selected enzymes and hormone levels, particularly testosterone and estradiol. Gut microbial enzymes & beta;-glucuronidase and & beta;-glucosidase may be used as biomarkers for early detection and monitoring of PCOS in women with metabolic challenges. It could lead to improved diagnostic tools and treatment options.

Automated summary

PCOS is an endocrine disorder characterized by hormonal imbalances and metabolic disturbances in women of reproductive age. This study investigates the correlation between gut microbial enzymes β-glucuronidase and β-glucosidase and PCOS, as well as their association with hormone levels and other clinical parameters. The results show significantly higher levels of β-glucuronidase and β-glucosidase activity in PCOS women compared to controls, and intriguing connections with hormone levels. These microbial enzymes may serve as biomarkers for early detection and monitoring of PCOS, leading to improved diagnosis and treatment options.